Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.77 |
| ▸ | FAP | Q12884 | 2/20 | 0.77 |
| ▸ | USP2 | O75604 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | NR1I2 | O75469 | 5/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | ALB | P02768 | 1/20 | 0.63 |
| ▸ | PPARG | P37231 | 1/20 | 0.63 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.63 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.63 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.62 |
| ▸ | APEX1 | P27695 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10745389 | 1.00 | PTGS1 (1.00) | PTGS1MAPTALDH1A1FAPUSP2 | |
| SCHEMBL2369390 | 1.00 | PTGS1 (1.00) | PTGS1MAPTALDH1A1FAPUSP2 | |
| SCHEMBL611675 | 1.00 | PTGS1 (1.00) | PTGS1MAPTALDH1A1FAPUSP2 | |
| SCHEMBL9661209 | 1.00 | PTGS1 (1.00) | PTGS1MAPTALDH1A1FAPUSP2 | |
| SCHEMBL9661218 | 1.00 | PTGS1 (1.00) | PTGS1MAPTALDH1A1FAPUSP2 | |
| Hydrochloric Acid SCHEMBL31060244 | 0.99 | PTGS1 (0.99) | PTGS1MAPTALDH1A1FAPUSP2 | |
| Hydrochloric Acid SCHEMBL10794744 | 0.99 | PTGS1 (0.99) | PTGS1MAPTALDH1A1FAPUSP2 | |
| Hydrochloric Acid SCHEMBL29643461 | 0.99 | PTGS1 (0.99) | PTGS1MAPTALDH1A1FAPUSP2 | |
| Hydrochloric Acid SCHEMBL10794747 | 0.99 | PTGS1 (0.99) | PTGS1MAPTALDH1A1FAPUSP2 | |
| Hydrochloric Acid SCHEMBL1649857 | 0.99 | PTGS1 (0.97) | PTGS1MAPTALDH1A1FAPUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1927 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4566590-A1 | TASTE-MASKING MICROSPHERE, PREPARATION PROCESS THEREFOR, AND USE THEREOF | Harbin Kanon Pharmaceutical Co., Ltd (CN) | 2025-06-11 | — | — | EP | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20240173512-A1 | METHODS FOR POTENTIATING ANTIMICROBIAL AGENTS | STREETERVILLE CAPITAL, LLC | 2024-05-30 | — | — | US | claimed |
| US-11890421-B2 | Methods for potentiating antimicrobial agents | BEYOND AIR LTD (IL) | 2024-02-06 | — | — | US | claimed |
| EP-4301466-A1 | B-LACTAMASE INHIBITORS AND USES THEREOF | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-01-10 | — | — | EP | claimed |
| CN-117343131-A | Snake venom polypeptide and application thereof | 湖南农业大学 | 2024-01-05 | — | — | CN | claimed |
| CN-116407503-A | Blank liposome composition with pentacyclic triterpene compound as membrane material, and preparation method and application thereof | 复旦大学 | 2023-07-11 | — | — | CN | claimed |
| EP-3337456-B1 | LIPOSOMES WITH GINSENOSIDE AS MEMBRANE MATERIAL AND PREPARATIONS AND USE THEREOF | SHANGHAI GINPOSOME PHARMATECH CO LTD (CN) | 2022-10-26 | — | — | EP | claimed |
| WO-2022187362-A1 | Β-LACTAMASE INHIBITORS AND USES THEREOF | CASE WESTERN RESERVE UNIVERSITY (US) | 2022-09-09 | — | — | WO | claimed |
| US-11311599-B2 | β-1,3-glucan-peptide complex: compositions and methods | QUEGEN BIOTECH CO., LTD. (KR) | 2022-04-26 | — | — | US | claimed |
| EP-1012139-A1 | AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS | Naeja Pharmaceutical Inc. (CA) | 2000-06-28 | — | — | EP | claimed |
| US-5994340-A | SYNERGISTIC MIXTURE WITH ANTIBIOTICS | SYNPHAR LABORATORIES, INC. (CA) | 1999-11-30 | — | — | US | claimed |
| WO-1999010324-A1 | AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS | NAEJA PHARMACEUTICAL INC. (CA) | 1999-03-04 | — | — | WO | claimed |
| US-5763603-A | HIGH BETA-LACTAMASE INHIBITORY ACTIVITY IN COMBINATION WITH BETA-LACTAM ANTIBIOTICS | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1998-06-09 | — | — | US | claimed |
| EP-0640607-B1 | 2-Beta-alkenyl-penem-sulfonyl compounds as beta-lacterase inhibitors | HOFFMANN LA ROCHE (CH) | 1997-02-05 | — | — | EP | claimed |
| EP-0680322-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS | SMITHKLINE BEECHAM PLC (GB) | 1995-11-08 | — | — | EP | claimed |
| EP-0678095-A1 | CRYSTALLINE PENICILLIN DERIVATIVE, AND ITS PRODUCTION AND USE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-10-25 | — | — | EP | claimed |
| CN-1106408-A | 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors 2-beta-alkenyl-penam-sulfonverbindungen als beta-lactamase-hemmer | HOFFMANN LA ROCHE (CH) | 1995-08-09 | — | — | CN | claimed |
| WO-1995012601-A1 | CRYSTALLINE PENICILLIN DERIVATIVE, AND ITS PRODUCTION AND USE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-05-11 | — | — | WO | claimed |
| WO-1994016696-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS | SMITHKLINE BEECHAM PLC (GB) | 1994-08-04 | — | — | WO | claimed |